A study of topical and systemic prostaglandin E1 and survival of experimental skin flaps.
A study has been undertaken to investigate Prostaglandin E1 administration procedure for improving flap survival. Whether the drug was administered continuously or transcutaneously using a silicone gel drug delivery system; or was topically injected into the critical zone of the flap; or was intraperitoneally administered intermittently over an hour after surgery a statistically significant improvement of flap survival occurred (P < 0.01, Student's t-test). However, no improvement of flap survival was seen when the drug was administered only once intraperitoneally immediately after flap elevation, although administered doses of the drug in those rats was equal to the doses in the rats which received intermittent administration of the drug intraperitoneally over an hour after surgery.
Sawada
Y
Y
Department of Plastic and Reconstructive Surgery, Hirosaki University School of Medicine, Japan.
Sugawara
M
M
Hatayama
I
I
Sone
K
K
D000279:Administration, Cutaneous; D000287:Administration, Topical; D000527:Alprostadil / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D051381:Rats; D011923:Rats, Nude; D013524:Surgical Flaps / Q000502:physiology*; D013997:Time Factors
D000527:Alprostadil